Where do MBX Biosciences, Inc.'s ratios come from?

Every ratio is computed from MBX Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-25.7%+2.0pp	-27.8%-3.3pp	-24.4%—	——	——
Return on assets	-24.8%+1.8pp	-26.6%-3.0pp	-23.6%—	——	——
Return on invested capital	-33%+6.0pp	-39%+20.8pp	-59.8%—	——	——
Liquidity
Current ratio	30.8×+6.2×	24.6×-8.3×	33×+13.5×	19.5×-3.8×	23.3×-0.9×
Quick ratio	30.8×+6.2×	24.6×-8.3×	33×+13.5×	19.5×-3.8×	23.3×-0.9×
Cash ratio	3.1×-1.8×	4.9×-13.6×	18.5×+15.1×	3.4×+0.5×	2.9×-1.6×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$9.40-7.1%	$10.11-10.7%	$11.33+72.9%	$6.55-7.0%	$7.05-70.9%
Valuation
Market capitalization	$1.42B+0.1%	$1.42B+81.0%	$782.52M+112%	$369.34M+49.7%	$246.67M-59.9%
Enterprise value	$1.37B+2.4%	$1.34B+140%	$560.02M+69.6%	$330.21M+52.2%	$216.9M-61.7%
Price / book	3.2×-0.6×	3.8×+1.8×	2×+0.3×	1.7×+0.6×	1×-1.3×
Free cash flow yield	-5.6%+0.2pp	-5.8%+4.3pp	-10.1%+9.3pp	-19.4%+7.9pp	-27.3%-18.3pp
Earnings yield	-6.1%0.0pp	-6.1%+4.1pp	-10.3%+10.6pp	-20.9%+8.9pp	-29.8%-19.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do MBX Biosciences, Inc.'s ratios come from?: Every ratio is computed from MBX Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.